316 related articles for article (PubMed ID: 32314798)
1. COVID-19 infection in patients with sickle cell disease.
Hussain FA; Njoku FU; Saraf SL; Molokie RE; Gordeuk VR; Han J
Br J Haematol; 2020 Jun; 189(5):851-852. PubMed ID: 32314798
[No Abstract] [Full Text] [Related]
2. A Saudi family with sickle cell disease presented with acute crises and COVID-19 infection.
Al-Hebshi A; Zolaly M; Alshengeti A; Al Qurainees G; Yamani S; Hamdan N; Alwasaidi T
Pediatr Blood Cancer; 2020 Sep; 67(9):e28547. PubMed ID: 32648991
[No Abstract] [Full Text] [Related]
3. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).
Foldes D; Hinton R; Arami S; Bain BJ
Am J Hematol; 2020 Jul; 95(7):861-862. PubMed ID: 32298486
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 infection in a highly experienced person living with HIV.
Di Giambenedetto S; Del Giacomo P; Ciccullo A; Porfidia A; De Matteis G; Cianci R; De Vito F; Dusina A; Borghetti A; Tumbarello M
AIDS; 2020 Jul; 34(8):1257-1258. PubMed ID: 32501851
[No Abstract] [Full Text] [Related]
5. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
Martín-Moro F; Marquet J; Piris M; Michael BM; Sáez AJ; Corona M; Jiménez C; Astibia B; García I; Rodríguez E; García-Hoz C; Fortún-Abete J; Herrera P; López-Jiménez J
Br J Haematol; 2020 Jul; 190(1):e16-e20. PubMed ID: 32379921
[No Abstract] [Full Text] [Related]
6. Severe COVID-19 infection associated with endothelial activation.
Escher R; Breakey N; Lämmle B
Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
[No Abstract] [Full Text] [Related]
7. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.
Wahlster L; Weichert-Leahey N; Trissal M; Grace RF; Sankaran VG
Pediatr Blood Cancer; 2020 Sep; 67(9):e28382. PubMed ID: 32495391
[No Abstract] [Full Text] [Related]
8. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
[No Abstract] [Full Text] [Related]
9. COVID-19 and QT interval prolongation: more than just drug toxicity?
Merino JL; Martínez-Cossiani M; Iniesta A; Escobar C; Rey JR; Castrejón-Castrejón S
Europace; 2020 Oct; 22(10):1479. PubMed ID: 32441761
[No Abstract] [Full Text] [Related]
10. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
11. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
Hindilerden F; Yonal-Hindilerden I; Akar E; Kart-Yasar K
Thromb Res; 2020 Nov; 195():136-138. PubMed ID: 32688098
[No Abstract] [Full Text] [Related]
12. COVID-19 infection and sickle cell disease: a UK centre experience.
McCloskey KA; Meenan J; Hall R; Tsitsikas DA
Br J Haematol; 2020 Jul; 190(2):e57-e58. PubMed ID: 32369606
[No Abstract] [Full Text] [Related]
13. Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.
Tonen-Wolyec S; Marini Djang'eing'a R; Kambale-Kombi P; Tshilumba CK; Bélec L; Batina-Agasa S
Hematology; 2020 Dec; 25(1):280-282. PubMed ID: 32657260
[No Abstract] [Full Text] [Related]
14. COVID-19 Clinical Trials: Unraveling a Methodological Gordian Knot.
Mathioudakis AG; Fally M; Hashad R; Knight S; Felton T; Vestbo J
Am J Respir Crit Care Med; 2020 Sep; 202(5):635-637. PubMed ID: 32634026
[No Abstract] [Full Text] [Related]
15. Sex differences in COVID-19 course and outcome: progesterone should not be neglected.
Jakovac H
J Appl Physiol (1985); 2020 Nov; 129(5):1007-1008. PubMed ID: 33096966
[No Abstract] [Full Text] [Related]
16. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.
Li J; Wang X; Chen J; Cai Y; Deng A; Yang M
Br J Haematol; 2020 Jul; 190(1):24-27. PubMed ID: 32379894
[No Abstract] [Full Text] [Related]
17. COVID-19 Presenting as Acute Hepatitis.
Wander P; Epstein M; Bernstein D
Am J Gastroenterol; 2020 Jun; 115(6):941-942. PubMed ID: 32301760
[No Abstract] [Full Text] [Related]
18. Peripheral blood morphologic findings in patients with COVID-19.
Sadigh S; Massoth LR; Christensen BB; Stefely JA; Keefe J; Sohani AR
Int J Lab Hematol; 2020 Dec; 42(6):e248-e251. PubMed ID: 32730694
[No Abstract] [Full Text] [Related]
19. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
Hanley B; Roufosse CA; Osborn M; Naresh KN
Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
[No Abstract] [Full Text] [Related]
20. Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.
Lei Y; Song Y; Shu Y; Zhao Y; Huo X; Wang H; Zeng Y; Yu X; Li X; Ye G; Fang B; Han S; Li R; Liu L
J Microbiol Immunol Infect; 2020 Aug; 53(4):657-659. PubMed ID: 32482367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
